The Brightline Initiative Announces Research Collaborations with Technical University of Denmark, University of Tokyo Global Teamwork Lab and the Massachusetts Institute of Technology Consortium for Engineering Program Excellence
The Brightline Initiative today announced research collaborations with Technical University of Denmark (DTU), University of Tokyo Global Teamwork Lab (GTL) and the Massachusetts Institute of Technology (MIT) Consortium for Engineering Program Excellence (CEPE). The initiative will focus on cutting-edge research and solutions for strategy implementation.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180130005754/en/
Launched in early 2017 by Project Management Institute (PMI), The Boston Consulting Group (BCG) and the Agile Alliance, the Brightline™ Initiative is a non-commercial coalition of leading global organizations dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery. The Brightline Initiative focuses its work on three key areas: Thought and Practice Leadership, Networking and Capability Building.
“At DTU we are excited to join the Brightline coalition. It is DTU’s mission to create tangible societal benefits. That is why, when we create new scientific insights and technologies we also focus on implementing them in the day-to-day operations of organizations and on a broader system level. Therefore, we believe our goals and those of Brightline align very well,” said Søren Salomo, Head of Department, DTU Management Engineering.
“We are looking forward to making our contribution to improving strategy implementation, particularly by our research on better managing the associated risks and uncertainties in technology-driven organizations,” said Josef Oehmen, Associate Professor at DTU.
“The collaboration with the Brightline Initiative presents a unique venue to explore the intersection of strategy development and planning with the pragmatic aspects of operations, organizational learning, and change. We’re particularly excited for the opportunity to develop sophisticated new research methods to uncover original insights into how decisions are made and translated into action and results,” said Eric Rebentisch, Research Associate at MIT.
Strategy is a living thing that adapts.  In a world with constant disruptions, an organization needs to engage with its ecosystem in designing and implementing its strategy. Collaboration and communication, knowledge and capabilities form the cornerstone of successful strategy executive.
Dr. Kazuo Hiekata, Associate Professor at The University of Tokyo, noted, "The GTL team is evolving methods and tools for system of systems to facilitate communication across boundaries. Our joint activity with Brightline Initiative will deliver both excellent research outcomes and significant impact to the society, by connecting executives and experienced employees in novel ways of communication." Dr. Kenji Tanaka, Project Associate Professor, added, ”Established industries such as the energy sector are required to change significantly from existing ways with the emergence of new technologies and services. The strategy and execution for established business should differ greatly."
Dai Ike, GTL Research Coordinator and GPD Japan CEO, further commented, "Japanese companies are seeking an advanced methodology and cross-boundary teams to execute the complex and diverse projects which directly link to the corporate strategy. However, at the same time, those companies hesitate to challenge the new way of business until other companies succeed. GTL success stories are exactly what companies are looking for."
Brightline Executive Director Ricardo Vargas highlights, “The collaborations with DTU, GTL, and MIT Research entities reinforce Brightline’s mission in bridging the gap between strategy design and delivery through cutting-edge research. Organizations and leaders will benefit from best practices in their endeavor for strategy delivery in this era of disruptive innovation. DTU, GTL and the MIT groups bring unique perspectives from their research fields. Their experience and knowledge on strategy will add enormous value in our collective quest to succeed in strategy initiative management.”
About Brightline Initiative
The Brightline™ Initiative is a non-commercial coalition of leading global organizations dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery. Brightline provides organizations with three key benefits that will improve their ability to deliver on strategic intent: Thought and Practice Leadership, Networking, and Capability Building. Learn more at www.brightline.org.
About Technical University of Denmark
The Technical University of Denmark is at the academic and
multidisciplinary forefront of the technical and the natural
sciences—with new initiatives in a number of demanding engineering
disciplines, including sustainable energy technology and life science.
About University of Tokyo Global Teamwork Lab (GTL)
The University of Tokyo Global Teamwork Lab (GTL) is an
industry-university partnership for research, workshops, and education
on teamwork across boundaries. The GLT research focuses on the
underlying mechanisms and dynamics of performance under complexity.
1] Economist Intelligence Unit (EIU), “Closing the Gap: Designing and Delivering a Strategy that Works”, 2017.
The Brightline Initiative
Organizations Relationship Manager
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha